Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex
Mosaic secured the latest pieces in its medicine combination strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex
James Waldron
Apr 24, 2025 10:00am
Boehringer slots synthetic lethal program into oncology pipeline
Apr 23, 2025 7:45am
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
Apr 23, 2025 6:35am
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
Apr 18, 2025 7:40am
Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics
Apr 17, 2025 8:51am
J&J calls time on Addex partnership a year after epilepsy fail
Apr 17, 2025 7:05am
